Thompson Elizabeth H.z.
CIK 0001861477
EVP, Research & DevelopmentDirector
Filings
19
Latest Mar 26, 2026
Issuers covered
3
Showing
19 of 19
Page 1
Track record
1 of 2 open-market trades scored (50% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +0.2% | +0.2% | +0.2% | +0.2% |
| 90 days | - | - | - | - | - | - |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Thompson Elizabeth H.z. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IGMS | Igm Biosciences, Inc. | 9 | Aug 14, 2025 |
| HZNP | Horizon Therapeutics Public Ltd Co | 6 | Oct 6, 2023 |
| ACAD | Acadia Pharmaceuticals Inc | 4 | Mar 26, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|